intoDNA is a biotech company that offers a unique research service based on their proprietary technology STRIDE® - the first ever, fluorescence-based technology for direct, super-sensitive and specific detection of DNA ends.
STRIDE is applied in precise DNA damage detection or detection of DNA fragments in any type of biological material.
We support our partners and projects within the area of precision medicine that develop DDR targeted therapies. Our help focuses on revealing mechanisms of action of the drugs and evaluation of efficiency or pharmacodynamics of the compounds.
intoDNA is on a mission to enhance understanding and quality of DNA damage diagnostics and to improve any therapies where DNA integrity matters.